David-Alexandre C Gros Insider Trading
Get free email notifications about insider trading for David-Alexandre C Gros.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David-Alexandre C Gros. David-Alexandre C Gros is a President & COO in NEUROCRINE BIOSCIENCES INC ($NBIX) and a SVP, Chief Business Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and an Chief Executive Officer in Novus Therapeutics, Inc. ($NVUS).
Address: 300 THIRD STREET CAMBRIDGE 02142 MA
Companies in which David-Alexandre C Gros is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Trading Symbol: ALNYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David-Alexandre C Gros: SVP, Chief Business Officer
Holdings: 1,000 shares
Current Value: $40,460
Latest Transaction: Dec 22 2016
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eledon Pharmaceuticals, Inc.
Trading Symbol: ELDNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David-Alexandre C Gros: Chief Executive Officer
Holdings: 3,000 shares
Current Value: $2,730
Latest Transaction: Jun 10 2021
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROCRINE BIOSCIENCES INC
Trading Symbol: NBIXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David-Alexandre C Gros: President & COO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 08 2017
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David-Alexandre C Gros
Sentiment: All, ALNY, ELDN, NBIX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | ELDN | Eledon Pharmaceuti ... | Gros David-Alexandre C | Chief Executive Off ... | Buy | P | 8.01 | 3,000 | 24,030 | 3,000 | 0 to 3 K |
Sep 15 2020 | NVUS | Novus Therapeutics ... | Gros David-Alexandre C | Chief Executive Off ... | Option Exercise | A | 500.00 | 18,278 | 9,139,000 | 18,278 | |
Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Gros David-Alexandre C | President & COO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Feb 02 2017 | NBIX | NEUROCRINE BIOSCIE ... | Gros David-Alexandre C | President & COO | Option Exercise | A | 42.55 | 350,000 | 14,892,500 | 350,000 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Buy | P | 62.75 | 900 | 56,475 | 1,000 | 100 to 1,000 (+900.00 %) |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Buy | P | 62.74 | 100 | 6,274 | 100 | 0 to 100 |